Biology Reference
In-Depth Information
73. Penkowa M, Giralt M, Lago N, Camats J, Carrasco J, Hernández J, et al. Astrocyte-
targeted expression of IL-6 protects the CNS against a focal brain injury. Exp Neurol
2003;181(2):130-48.
74. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB, et al.
Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.
Proc Natl Acad Sci USA 1993;90(21):10061-65.
75. Shohami E, Ginis I, Hallenbeck JM. Dual role of tumour necrosis factor alpha in brain
injury. Cytokine Growth Factor Rev 1999;10:119-30.
76. Fan L, Young PR, Barone FC, Feuerstein GZ, Smith DH, McIntosh TK. Experimental
brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the
CNS. Brain Res Mol Brain Res 1996;36(2):287-91.
77. Knoblach SM, Fan L, Faden AI. Early neuronal expression of tumor necrosis factor-alpha
after experimental brain injury contributes to neurological impairment. J Neuroimmunol
1999;95(1-2):115-25.
78. Rostworowski M, Balasingam V, Chabot S, Owens T, Yong VW. Astrogliosis in the neo-
natal and adult murine brain post-trauma: elevation of inflammatory cytokines and the
lack of requirement for endogenous interferon-gamma. J Neurosci 1997;17(10):3664-74.
79. Goodman JC, Robertson CS, Grossman RG, Narayan RK. Elevation of tumor necrosis
factor in head injury. J Neuroimmunol 1990;30(2-3):213-17.
80. Ross SA, Halliday MI, Campbell GC, Byrnes DP, Rowlands BJ. The presence of
tumour necrosis factor in CSF and plasma after severe head injury. Br J Neurosurg
1994;8(4):419-25.
81. Morganti-Kossman MC, Lenzlinger PM, Hans V, Stahel P, Csuka E, Ammann E, et al.
Production of cytokines following brain injury: beneficial and deleterious for the damaged
tissue. Mol Psychiatry 1997;2(2):133-36.
82. Kamm K, Vanderkolk W, Lawrence C, Jonker M, Davis AT. The effect of traumatic brain
injury upon the concentration and expression of interleukin-1 beta and interleukin-10 in
the rat. J Trauma 2006;60:152-57.
83. Crack PJ, Gould J, Bye N, Ross S, Ali U, Habgood MD, et al. The genomic profile of the
cerebral cortex after closed head injury in mice: effects of minocycline. J Neural Transm
2009;116:1-12.
84. Schroeter M, Kury P, Jander S. Inflammatory gene expression in focal cortical brain isch-
emia: differences between rats and mice. Brain Res Mol Brain Res 2003;117(1):1-7.
85. Shohami E, Bass R, Wallach D, Yamin A, Gallily R. Inhibition of tumor necrosis factor
alpha (TNF alpha) activity in rat brain is associated with cerebroprotection after closed
head injury. J Cereb Blood Flow Metab 1996;16(3):378-84.
86. Shohami E, Gallily R, Mechoulam R, Bass R, Ben-Hur T. Cytokine production in the
brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor
and an effective neuroprotectant. J Neuroimmunol 1997;72(2):169-77.
87. Marklund N, Keck C, Hoover R, Soltesz K, Millard M, LeBold D, et al. Administration
of monoclonal antibodies neutralizing the inflammatory mediators tumor necrosis factor
alpha and interleukin-6 does not attenuate acute behavioral deficits following experimen-
tal traumatic brain injury in the rat. Restor Neurol Neurosci 2005;23(1):31-42.
88. Scherbel U, Raghupathi R, Nakamura M, Saatman KE, Trojanowski JQ, Neugebauer E,
et al. Differential acute and chronic responses of tumor necrosis factor-deficient mice to
experimental brain injury. Proc Natl Acad Sci USA 1999;96(15):8721-26.
89. Sullivan PG, Bruce-Keller AJ, Rabchevsky AG, Christakos S, Clair DK, Mattson MP,
et al. Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor
necrosis factor receptors after traumatic brain injury. J Neurosci 1999;19(15):6248-56.
